Comprehensive personalized approach to the diagnosis and treatment of pheochromocytoma and paraganglioma
Open Access
- 24 October 2025
- journal article
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 92 (5) , 50-59
Abstract
Objective. To evaluate the effectiveness of a comprehensive approach to the diagnosis and treatment of pheochromocytoma and paraganglioma with a special focus on the role of selective venous blood sampling, X–ray endovascular selective electrocoagulation occlusion, and biochemical stratification in optimizing surgical tactics in domestic clinical practice. Materials and methods. The study included 248 patients with morphologically confirmed pheochromocytomas and paragangliomas who were treated at the O. O. Shalimov National Scientific Center for Surgery and Transplantology in 2016–2025: 129 (52.0%) women and 119 (48.0%) men, with an average age of 47.0 (± 10.0) years. Shalimov National Scientific Center for Surgery and Transplantology in 2016–2025: 129 (52.0%) women and 119 (48.0%) men, with a mean age of (43.8 ± 12.4) years. All patients underwent blood plasma metanephrine level determination using high–performance liquid chromatography with tandem mass spectrometry, as well as computed tomography and magnetic resonance imaging. Selective venous blood sampling was performed in 35 patients with complex diagnoses, and selective endovascular electrocoagulation occlusion was performed in 183 patients as part of preoperative preparation. Next–generation sequencing genetic testing was performed in 12 patients. All patients underwent surgery after adequate α–blockade. Results. Elevated metanephrine levels were detected in 91.9% of patients. In 75% of patients with "biochemically silent" tumors, the diagnosis was established by determining the level of 3–methoxytyramine. Selective venous blood sampling allowed lateralization in 80% of patients and changed surgical tactics in 31.4% of patients, avoiding bilateral adrenalectomy in 5 patients. X–ray endovascular selective electrocoagulation occlusion led to normalization of metanephrine levels in 66.7% and ensured hemodynamic stability during surgery in 91.8% of patients. The average blood loss after this procedure was (66.4 ± 12.2) ml. Mutations in genes were detected in 83.3% of patients, mainly in the SDHB gene (90%). The overall incidence of postoperative complications was 8.9%, and the three–year recurrence–free survival rate was 92.1%. Conclusions. A comprehensive approach using selective venous blood sampling and X–ray endovascular selective electrocoagulation occlusion significantly improves the results of treatment for pheochromocytoma and paraganglioma. Selective venous blood sampling allows optimizing surgical tactics and avoiding unnecessary bilateral adrenalectomies. X–ray endovascular selective electrocoagulation occlusion effectively reduces hormonal load and intraoperative risks. Determination of 3–methoxytyramine levels increases diagnostic sensitivity in patients with "biochemically silent" tumors. Genetic testing is critical for predicting the course of the disease.Keywords
This publication has 30 references indexed in Scilit:
- The diagnosis and management of pheochromocytoma and paraganglioma during pregnancyReviews in Endocrine and Metabolic Disorders, 2023
- Pathophysiology and Acute Management of Tachyarrhythmias in PheochromocytomaJACC, 2020
- SDHB-related pheochromocytoma and paraganglioma penetrance and genotype–phenotype correlationsJournal of Cancer Research and Clinical Oncology, 2017
- Genetics of Pheochromocytomas and ParagangliomasEndocrinology and Metabolism Clinics of North America, 2017
- Minimally invasive approach for adrenal lesions: Systematic review of laparoscopic versus retroperitoneoscopic adrenalectomy and assessment of risk factors for complicationsInternational Journal of Surgery, 2016
- Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic ParagangliomaCurrent Oncology Reports, 2013
- Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation statusEuropean Journal of Cancer, 2012
- Hypertension in Pheochromocytoma: Characteristics and TreatmentEndocrinology and Metabolism Clinics of North America, 2011
- Adrenal causes of hypertension: Pheochromocytoma and primary aldosteronismReviews in Endocrine and Metabolic Disorders, 2007
- Posterior retroperitoneoscopic adrenalectomy—results of 560 procedures in 520 patientsSurgery, 2006